The Beauty Health Co. (SKIN)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about The Beauty Health Co. (SKIN)
Company Performance

Current Price

as of Oct 29, 2024

$1.79

P/E Ratio

N/A

Market Cap

$219.52M

Description

The Beauty Health Co. engages in manufacturing and selling of serum-based hydradermabrasion systems and aesthetic products. The company was founded in 1997 and is headquartered in Long Beach, CA.

Metrics

Overview

  • HQLong Beach, CA
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerSKIN
  • Price$1.79+1.13%

Trading Information

  • Market Cap$219.52M
  • Float62.36%
  • Average Daily Volume (1m)807,465
  • Average Daily Volume (3m)1,405,343
  • EPS-$0.63

Company

  • Revenue$366.21M
  • Rev Growth (1yr)-22.88%
  • Net Income$0.20M
  • Gross Margin45.19%
  • EBITDA Margin-14.56%
  • EBITDA-$13.19M
  • EV$490.56M
  • EV/Revenue1.34
  • P/EN/A
  • P/S0.69
  • P/B3.21
Documents
SEC Filings
8-K (2024-10-15)
8-K (2024-08-30)
8-K (2024-08-08)
8-K (2024-06-11)
8-K (2024-05-09)
8-K (2024-04-09)
8-K (2024-04-08)
8-K (2024-03-12)
8-K (2023-12-01)
8-K (2023-11-16)
8-K (2023-11-13)
8-K (2023-09-13)
8-K (2023-08-09)
8-K (2023-06-21)
8-K (2023-05-10)
8-K (2023-04-19)
8-K (2023-04-14)
8-K (2023-03-02)
8-K (2023-02-28)
8-K (2023-01-06)
10-Q (2024-08-08)
10-Q (2024-05-09)
10-Q (2023-11-14)
10-Q (2023-08-09)
10-Q (2023-05-10)
10-K (2024-03-12)
10-K (2023-03-01)
Factset Street Account
StreetAccount Metrics Recap - Beauty Health Company Q3 Earnings ($3.90, 0.00) (2023-11-14T15:59:12Z)
StreetAccount Consensus Metrics Preview - Beauty Health Company Q3 Earnings ($4.04, 0.00) (2023-11-09T14:02:02Z)
Street Takeaways - Beauty Health Company Q3 Earnings ($1.57, -2.33) (2023-11-14T20:06:34Z)
CORRECTION: Beauty Health Company Q3 adj. gross margin 62.5% vs FS $67.1% ($1.62, -2.28) (2023-11-14T16:09:57Z)
Beauty Health Company reports Q3 adjusted EBITDA $9.1M vs FactSet $21.6M [8 est, $18.4-24.1M] ($3.92, 0.00) (2023-11-13T21:13:21Z)
Beauty Health Company President & CEO Andrew Stanleick to depart company and relinquish his Board seat, effective 19-Nov ($3.95, 0.00) (2023-11-13T21:07:29Z)
Beauty Health Company downgraded to underweight from overweight at Piper Sandler ($3.90, 0.00) (2023-11-14T01:17:22Z)
Beauty Health Company downgraded to underweight from neutral at JPMorgan ($3.90, 0.00) (2023-11-14T10:41:04Z)
Beauty Health Company downgraded to underperform from market perform at Raymond James ($3.90, 0.00) (2023-11-14T11:39:37Z)
Beauty Health Company downgraded to market perform from outperform at William Blair ($3.90, 0.00) (2023-11-14T12:30:20Z)
Beauty Health Company downgraded to market perform from outperform at TD Cowen ($3.90, 0.00) (2023-11-14T10:31:38Z)
Beauty Health Company downgraded to hold from buy at Jefferies ($1.39, 0.00) (2023-11-15T10:50:24Z)
Beauty Health Company downgraded to hold from buy at Canaccord Genuity ($3.90, 0.00) (2023-11-14T10:43:41Z)
Beauty Health Company downgraded to hold from buy at Benchmark Company LLC ($3.90, 0.00) (2023-11-14T12:26:36Z)
Beauty Health Company discloses commitment to phase 1 of cost savings and optimization plan - 8-K ($1.80, -0.11) (2023-11-16T16:14:58Z)
Earnings Calls
Earnings Report 2024Q2
Earnings Report 2024Q1
Earnings Report 2023Q4
Earnings Report (2023-11-13)
Earnings Report (2023-08-09)
Factset
Factset Business Description